Deutsche Bank
MBIO icon

Deutsche Bank’s Mustang Bio MBIO Stock Holding History

Deutsche Bank’s Portfolio MBIO Stock Details MBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-50
Closed -$38K – 4244
2022
Q1 		$38K Sell
50
-6
-11% -$4.93K ﹤0.01% 3916
2021
Q4 		$70K Buy
56
+3
+6% +$4.84K ﹤0.01% 3849
2021
Q3 		$108K Sell
53
-2
-4% -$4.3K ﹤0.01% 3874
2021
Q2 		$137K Buy
55
+11
+25% +$27K ﹤0.01% 3996
2021
Q1 		$109K Sell
44
-4
-8% -$11.9K ﹤0.01% 3931
2020
Q4 		$137K Buy
48
+28
+140% +$66.9K ﹤0.01% 3670
2020
Q3 		$48K Buy
20
+1
+5% +$2.46K ﹤0.01% 3909
2020
Q2 		$44K Buy
19
+6
+46% +$14K ﹤0.01% 3866
2020
Q1 		$25K Hold
13
– – ﹤0.01% 3849
2019
Q4 		$40K Buy
13
+2
+18% +$4.58K ﹤0.01% 4061
2019
Q3 		$25K Sell
11
-13
-54% -$35.6K ﹤0.01% 4240
2019
Q2 		$66K Sell
24
-4
-14% -$11.4K ﹤0.01% 4390
2019
Q1 		$69K Hold
28
– – ﹤0.01% 4453
2018
Q4 		$61K Sell
28
-22
-44% -$66.9K ﹤0.01% 4405
2018
Q3 		$224K Buy
50
+7
+16% +$35K ﹤0.01% 4188
2018
Q2 		$220K Buy
+43
New +$272K ﹤0.01% 4249

Other funds holding MBIO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return

Deutsche Bank's MBIO Position: Q2 2022 in Review

Deutsche Bank sold out of Mustang Bio (MBIO) in Q2 2022, closing a stake of 50 shares — an estimated $38K sold.

Deutsche Bank first reported a position in MBIO in Q2 2018 and held it in 16 quarters. The position peaked at $224K in Q3 2018. 71 funds tracked by Wall St. Rank hold MBIO as of Q2 2022.

  • Deutsche Bank reported no remaining Mustang Bio position as of Q2 2022 after selling out during the quarter.
  • Deutsche Bank sold 50 Mustang Bio shares in Q2 2022, an estimated $38K.
  • Deutsche Bank first reported a position in Mustang Bio in Q2 2018 and held it in 16 quarters.
  • Deutsche Bank's Mustang Bio position peaked at $224K in Q3 2018.
  • 71 funds tracked by Wall St. Rank held Mustang Bio as of Q2 2022.

Based on Deutsche Bank's 13F filing for Q2 2022, filed 11 Aug 2022.